MeSH term
Frequency | Condition_Probility | Enzyme Inhibitors/pharmacology | 8 | 0.0 |
Phosphorylation | 54 | 0.0 |
Research Support, Non-U.S. Gov't | 188 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 89 | 0.0 |
Signal Transduction | 34 | 0.0 |
1-Phosphatidylinositol 3-Kinase/physiology | 4 | 3.0 |
Animals | 114 | 0.0 |
B-Lymphocytes/*physiology | 10 | 6.0 |
Calcium/metabolism | 14 | 0.0 |
Humans | 236 | 0.0 |
Mice | 70 | 0.0 |
Mice, Inbred C57BL | 14 | 0.0 |
Mice, Inbred CBA | 9 | 2.0 |
Protein-Tyrosine Kinase/*physiology | 16 | 11.0 |
Receptors, Antigen, B-Cell/physiology | 4 | 12.0 |
*Signal Transduction | 10 | 0.0 |
Tyrosine/metabolism | 13 | 1.0 |
Blotting, Western | 9 | 0.0 |
Dose-Response Relationship, Drug | 5 | 0.0 |
Female | 41 | 0.0 |
Mice, Inbred BALB C | 8 | 0.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors/metabolism | 7 | 17.0 |
Rats | 6 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Tumor Cells, Cultured | 24 | 0.0 |
Vincristine/pharmacology | 2 | 3.0 |
Agammaglobulinemia/enzymology | 3 | 100.0 |
B-Lymphocytes/metabolism | 6 | 3.0 |
Cell Line | 42 | 0.0 |
Chickens | 14 | 1.0 |
Enzyme Activation/physiology | 6 | 3.0 |
Mitogen-Activated Protein Kinase 8 | 2 | 2.0 |
Mitogen-Activated Protein Kinases/*metabolism | 3 | 0.0 |
Precipitin Tests | 7 | 0.0 |
Protein-Tyrosine Kinase/deficiency/genetics/*metabolism | 3 | 23.0 |
Receptors, Antigen, B-Cell/*metabolism | 9 | 11.0 |
Signal Transduction/physiology | 6 | 0.0 |
Transfection | 22 | 0.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
Androstadienes/pharmacology | 2 | 0.0 |
Cell Membrane/metabolism | 4 | 0.0 |
Immunoblotting | 3 | 0.0 |
Protein Binding | 16 | 0.0 |
Protein Transport | 3 | 0.0 |
Protein-Tyrosine Kinase/metabolism/*physiology | 2 | 7.0 |
Time Factors | 8 | 0.0 |
B-Lymphocytes/immunology | 3 | 0.0 |
Base Sequence | 47 | 0.0 |
Child | 34 | 0.0 |
DNA/chemistry/genetics | 2 | 0.0 |
DNA Mutational Analysis | 17 | 0.0 |
Family Health | 2 | 0.0 |
Male | 69 | 0.0 |
Mutation | 32 | 0.0 |
Pedigree | 12 | 0.0 |
Receptors, Antigen, B-Cell/*genetics | 2 | 18.0 |
Turkey | 2 | 1.0 |
Agammaglobulinemia/enzymology/*genetics | 4 | 100.0 |
Cell Transformation, Viral | 2 | 0.0 |
Comparative Study | 20 | 0.0 |
DNA, Complementary/genetics | 7 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
Herpesvirus 4, Human/physiology | 2 | 6.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Polymerase Chain Reaction | 18 | 0.0 |
Protein-Tyrosine Kinase/deficiency/genetics/*physiology | 3 | 50.0 |
X Chromosome/genetics | 15 | 7.0 |
Blood Proteins/*chemistry | 4 | 14.0 |
Glutathione Transferase/metabolism | 7 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Kinetics | 12 | 0.0 |
Lipids/metabolism | 2 | 0.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
Mutagenesis, Site-Directed | 12 | 0.0 |
Phosphatidylinositols/*metabolism | 2 | 2.0 |
Phosphoproteins/*chemistry | 3 | 10.0 |
Protein Structure, Tertiary | 16 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 10 | 1.0 |
Recombinant Fusion Proteins/metabolism | 9 | 0.0 |
Amino Acid Sequence | 54 | 0.0 |
Amino Acid Substitution | 6 | 0.0 |
Binding Sites | 22 | 0.0 |
Calcium Signaling/*physiology | 2 | 4.0 |
Cell Line, Tumor | 2 | 0.0 |
Flow Cytometry | 13 | 0.0 |
Gene Expression | 6 | 0.0 |
Mice, Knockout | 12 | 0.0 |
Mice, Transgenic | 6 | 0.0 |
Phenotype | 15 | 0.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 8 | 5.0 |
Circular Dichroism | 2 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Escherichia coli/metabolism | 2 | 0.0 |
Models, Molecular | 17 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/*chemistry | 3 | 15.0 |
src Homology Domains | 15 | 2.0 |
Adolescent | 24 | 0.0 |
Cell Differentiation | 12 | 0.0 |
Child, Preschool | 29 | 0.0 |
Infant | 19 | 0.0 |
Linkage (Genetics) | 34 | 1.0 |
X Chromosome | 21 | 4.0 |
Crotalid Venoms/pharmacology | 2 | 5.0 |
Models, Biological | 11 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 28 | 3.0 |
Lymphocyte Activation | 8 | 0.0 |
Molecular Sequence Data | 75 | 0.0 |
Adult | 29 | 0.0 |
Agammaglobulinemia/*genetics | 32 | 91.0 |
*Linkage (Genetics) | 20 | 1.0 |
*Mutation | 25 | 0.0 |
Protein-Tyrosine Kinase/*genetics | 43 | 20.0 |
*X Chromosome | 45 | 4.0 |
Lymphocyte Count | 4 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/biosynthesis/genetics | 2 | 4.0 |
Spleen/cytology/immunology/pathology | 2 | 66.0 |
Transgenes/immunology | 2 | 7.0 |
Chromatography, Gel | 2 | 0.0 |
Protein-Tyrosine Kinase/*chemistry/genetics/*metabolism | 3 | 17.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 3 | 1.0 |
*src Homology Domains | 4 | 2.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 8 | 1.0 |
Catalytic Domain | 2 | 0.0 |
Genes, Reporter | 6 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Protein-Tyrosine Kinase/chemistry/*metabolism | 7 | 18.0 |
Signal Transduction/*physiology | 6 | 0.0 |
Agammaglobulinemia/*diagnosis/*genetics | 3 | 100.0 |
Alleles | 3 | 0.0 |
Gene Deletion | 6 | 0.0 |
Protein-Tyrosine Kinase/genetics/metabolism | 2 | 2.0 |
Recurrence | 2 | 0.0 |
Agammaglobulinemia/genetics | 7 | 70.0 |
B-Lymphocytes/*immunology | 10 | 1.0 |
Exons | 12 | 0.0 |
Genome, Human | 2 | 0.0 |
Introns | 3 | 0.0 |
Isoenzymes/*genetics | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 19 | 0.0 |
Sequence Homology, Amino Acid | 19 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Antineoplastic Agents/*pharmacology | 4 | 0.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
Linkage (Genetics)/*genetics | 4 | 1.0 |
Mutation/*genetics | 7 | 0.0 |
Protein-Tyrosine Kinase/chemistry/*genetics | 9 | 50.0 |
X Chromosome/*genetics | 15 | 4.0 |
Enzyme Activation | 38 | 1.0 |
Enzyme Precursors/metabolism | 8 | 5.0 |
Hydrogen Peroxide/pharmacology | 2 | 0.0 |
Isoenzymes/chemistry/*metabolism | 2 | 14.0 |
Phospholipase C/chemistry/*metabolism | 3 | 50.0 |
Tyrosine/*metabolism | 3 | 0.0 |
3T3 Cells | 5 | 0.0 |
B-Lymphocytes/enzymology/immunology | 2 | 15.0 |
Peptide Mapping | 2 | 0.0 |
Protein Processing, Post-Translational | 3 | 0.0 |
Receptors, Antigen, B-Cell/*physiology | 10 | 13.0 |
Receptors, IgE/physiology | 2 | 22.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Transcription, Genetic | 10 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Catalysis | 3 | 0.0 |
Magnetic Resonance Spectroscopy | 3 | 0.0 |
Protein-Tyrosine Kinase/*chemistry/*metabolism | 4 | 26.0 |
Substrate Specificity | 5 | 0.0 |
Tyrosine/chemistry | 2 | 1.0 |
Agammaglobulinemia/diagnosis/*genetics | 4 | 80.0 |
Cells, Cultured | 16 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Korea | 2 | 0.0 |
Monocytes/metabolism | 3 | 0.0 |
Point Mutation | 9 | 0.0 |
Protein-Tyrosine Kinase/*genetics/metabolism | 6 | 12.0 |
Proteins/metabolism | 3 | 0.0 |
Thrombin/pharmacology | 3 | 1.0 |
Heterozygote | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Calcium/*metabolism | 4 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Phenylalanine/chemistry | 2 | 6.0 |
Blood Platelets/*enzymology | 2 | 2.0 |
*Dosage Compensation (Genetics) | 3 | 1.0 |
Heterozygote Detection | 6 | 1.0 |
Protein Kinase C/physiology | 2 | 1.0 |
Receptors, Antigen, B-Cell/genetics/*physiology | 2 | 66.0 |
Signal Transduction/genetics/*immunology | 3 | 3.0 |
Antibody Formation | 4 | 0.0 |
B-Lymphocytes/cytology/*enzymology | 3 | 60.0 |
Cell Cycle | 2 | 0.0 |
Gene Expression Regulation | 4 | 0.0 |
Mice, Mutant Strains | 10 | 1.0 |
Models, Immunological | 2 | 0.0 |
Receptors, Antigen, B-Cell/immunology | 2 | 8.0 |
src-Family Kinases/physiology | 5 | 15.0 |
Exons/genetics | 6 | 0.0 |
Introns/genetics | 2 | 0.0 |
Linkage (Genetics)/genetics | 4 | 1.0 |
Agammaglobulinemia/enzymology/genetics | 5 | 83.0 |
B-Lymphocytes/drug effects/enzymology/metabolism | 2 | 100.0 |
Blood Proteins/genetics | 2 | 3.0 |
Carrier Proteins/metabolism | 3 | 0.0 |
*Electromagnetic Fields | 2 | 6.0 |
B-Lymphocytes/*metabolism | 4 | 2.0 |
Transcription Factors/physiology | 3 | 1.0 |
COS Cells | 5 | 0.0 |
Recombinant Proteins/metabolism | 6 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Protein Conformation | 9 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Antigens, CD/metabolism | 2 | 0.0 |
Receptors, IgG/metabolism | 2 | 2.0 |
Age Factors | 2 | 0.0 |
Aged | 3 | 0.0 |
Middle Aged | 4 | 0.0 |
RNA Splicing | 3 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
B-Lymphocytes/cytology/enzymology/*immunology | 2 | 100.0 |
DNA-Binding Proteins | 2 | 2.0 |
Isoenzymes/metabolism | 8 | 1.0 |
Mitogen-Activated Protein Kinases/metabolism | 4 | 0.0 |
Phospholipase C/metabolism | 10 | 3.0 |
Protein-Tyrosine Kinase/genetics/*physiology | 2 | 9.0 |
GTP-Binding Proteins/*metabolism | 4 | 1.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 3 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 3 | 0.0 |
Restriction Mapping | 6 | 0.0 |
src-Family Kinases/metabolism | 7 | 3.0 |
Cytoplasm/enzymology | 2 | 2.0 |
Dimerization | 3 | 0.0 |
src Homology Domains/*physiology | 2 | 9.0 |
Genes, Immunoglobulin | 2 | 1.0 |
Hematopoiesis | 2 | 0.0 |
Protein-Tyrosine Kinase/deficiency/genetics | 2 | 66.0 |
Species Specificity | 2 | 0.0 |
Hela Cells | 5 | 0.0 |
Receptors, Antigen, B-Cell/metabolism | 8 | 16.0 |
Protein Binding/genetics | 2 | 0.0 |
Protein-Tyrosine Kinase/chemistry/*genetics/*metabolism | 2 | 28.0 |
Sequence Alignment | 14 | 0.0 |
Antibodies, Anti-Idiotypic/pharmacology | 2 | 6.0 |
Cell Differentiation/immunology | 2 | 0.0 |
Enzyme Activation/genetics/immunology | 2 | 10.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Phosphatidylinositol Phosphates/metabolism | 5 | 10.0 |
Agammaglobulinemia/*enzymology/*genetics | 5 | 100.0 |
Amino Acid Substitution/genetics | 3 | 1.0 |
Solubility | 2 | 0.0 |
Structure-Activity Relationship | 11 | 0.0 |
src Homology Domains/*genetics | 3 | 10.0 |
Immunoglobulin A/blood | 2 | 1.0 |
Immunoglobulin G/blood | 2 | 0.0 |
Immunoglobulin M/biosynthesis/blood | 2 | 66.0 |
Lipopolysaccharides/pharmacology | 2 | 0.0 |
Mutagenesis | 4 | 0.0 |
Protein-Tyrosine Kinase/genetics/*metabolism/physiology | 2 | 66.0 |
Drug Resistance, Neoplasm | 2 | 0.0 |
Cloning, Molecular | 12 | 0.0 |
Escherichia coli | 3 | 0.0 |
B-Lymphocytes/*enzymology/immunology | 2 | 28.0 |
Calcium Signaling | 2 | 2.0 |
Isoenzymes/*metabolism | 2 | 0.0 |
Phospholipase C/*metabolism | 3 | 2.0 |
Point Mutation/genetics | 3 | 1.0 |
RNA, Messenger/genetics | 7 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
DNA Primers | 15 | 0.0 |
Calcium/*physiology | 3 | 2.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
Enzyme Precursors/physiology | 3 | 21.0 |
*Nuclear Proteins | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Protein-Tyrosine Kinase/physiology | 2 | 1.0 |
*Cell Adhesion Molecules | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
*Lectins | 2 | 1.0 |
Protein Kinases/genetics | 2 | 3.0 |
Biological Transport | 2 | 0.0 |
Jurkat Cells | 6 | 0.0 |
Phosphoproteins/metabolism | 3 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/metabolism | 2 | 1.0 |
Rabbits | 3 | 0.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
Conserved Sequence/genetics | 2 | 1.0 |
Italy | 2 | 0.0 |
Syndrome | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 3 | 0.0 |
Receptors, IgG/physiology | 2 | 5.0 |
Hematopoietic Stem Cells/cytology/immunology | 2 | 6.0 |
DNA Primers/genetics | 3 | 0.0 |
*Apoptosis | 3 | 0.0 |
Cell Separation | 2 | 0.0 |
Immunoglobulin G/metabolism | 2 | 1.0 |
K562 Cells | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Signal Transduction/*immunology | 4 | 1.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 4 | 1.0 |
Signal Transduction/drug effects | 2 | 0.0 |
Agammaglobulinemia/enzymology/genetics/*immunology | 2 | 100.0 |
Immunophenotyping | 2 | 0.0 |
*Point Mutation | 7 | 0.0 |
Cell Division/immunology | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Agammaglobulinemia/*enzymology/*genetics/pathology | 2 | 100.0 |
Cell Differentiation/genetics/immunology | 2 | 2.0 |
Protein-Tyrosine Kinase/genetics | 3 | 2.0 |
Protein Kinase C/*metabolism | 2 | 0.0 |
Enzyme Precursors/*metabolism | 3 | 2.0 |
Proto-Oncogene Proteins/*metabolism | 4 | 0.0 |
Burkitt Lymphoma | 2 | 2.0 |
Diagnosis, Differential | 3 | 0.0 |
Cell Line, Transformed | 5 | 0.0 |
Consensus Sequence | 3 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Genetic Markers | 4 | 0.0 |
Drosophila | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Protein-Tyrosine Kinase/biosynthesis/*genetics | 3 | 33.0 |
*Adaptor Proteins, Signal Transducing | 6 | 0.0 |
Apoptosis | 4 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Inositol Phosphates/metabolism | 2 | 1.0 |
Receptors, Antigen, B-Cell/*immunology | 2 | 5.0 |
Recombinant Fusion Proteins/physiology | 2 | 0.0 |
Chromosome Mapping | 7 | 0.0 |
Models, Genetic | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
English Abstract | 3 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Immunologic Deficiency Syndromes/*enzymology/genetics/immunology | 3 | 100.0 |
X Chromosome/immunology | 2 | 66.0 |
Crystallography, X-Ray | 4 | 0.0 |
Inositol Phosphates/*metabolism | 3 | 9.0 |
*Phosphoproteins | 7 | 5.0 |
Computer Simulation | 2 | 0.0 |
Drug Design | 3 | 0.0 |
Agammaglobulinemia/*enzymology/genetics | 2 | 100.0 |
B-Lymphocytes/*enzymology | 3 | 15.0 |
Cross-Linking Reagents | 2 | 0.0 |
Phosphotyrosine/metabolism | 4 | 0.0 |
Protein-Tyrosine Kinase/chemistry/genetics/*metabolism | 2 | 8.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Enzyme Inhibitors/*pharmacology | 2 | 0.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors | 2 | 1.0 |
Antibody Specificity | 2 | 0.0 |
B-Lymphocytes/enzymology/*immunology | 2 | 33.0 |
B-Lymphocytes/cytology/*immunology | 3 | 4.0 |
Signal Transduction/genetics/immunology | 2 | 2.0 |
Platelet Activation | 2 | 1.0 |
DNA Transposable Elements | 4 | 2.0 |
Blood Proteins/chemistry | 6 | 27.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
*Sequence Homology, Amino Acid | 2 | 2.0 |
Enzyme Induction | 3 | 0.0 |
Immunoglobulin M/immunology | 2 | 1.0 |
Vanadates/pharmacology | 2 | 1.0 |
Guanosine 5'-O-(3-Thiotriphosphate)/metabolism | 2 | 2.0 |
Protein-Tyrosine Kinase/*genetics/immunology | 2 | 40.0 |
JNK Mitogen-Activated Protein Kinases | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 2 | 0.0 |
Protein Kinases/*metabolism | 2 | 0.0 |
Cell Adhesion/physiology | 2 | 0.0 |
Agammaglobulinemia | 2 | 100.0 |
B-Lymphocytes | 3 | 1.0 |
Enteritis/etiology | 2 | 40.0 |
Mast Cells/enzymology | 2 | 20.0 |
Enzyme Precursors/*physiology | 2 | 13.0 |
Macromolecular Substances | 2 | 0.0 |
Repetitive Sequences, Nucleic Acid | 3 | 0.0 |
*Transcription Factors, TFII | 2 | 1.0 |
Solutions | 2 | 1.0 |
Mice, Inbred DBA | 2 | 0.0 |
src-Family Kinases/*metabolism | 2 | 1.0 |
Agammaglobulinemia/diagnosis/*enzymology/*genetics | 2 | 100.0 |
Protein-Tyrosine Kinase/biosynthesis/genetics/*metabolism | 3 | 42.0 |
Computer Communication Networks | 2 | 15.0 |
*Databases, Factual | 3 | 5.0 |
Introns/*genetics | 2 | 1.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
*Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
DNA Mutational Analysis/methods | 2 | 0.0 |
Agammaglobulinemia/*enzymology | 4 | 100.0 |
*Ubiquitin-Protein Ligases | 2 | 0.0 |
Subcellular Fractions/enzymology | 2 | 2.0 |
Vaccinia virus | 2 | 9.0 |
Protein Folding | 2 | 0.0 |
Protein-Tyrosine Kinase/*chemistry/metabolism | 2 | 16.0 |
Cercopithecus aethiops | 2 | 0.0 |
Agammaglobulinemia/*genetics/metabolism | 2 | 100.0 |
Inositol 1,4,5-Trisphosphate/metabolism | 2 | 3.0 |
*Protein Structure, Secondary | 2 | 1.0 |
B-Lymphocytes/enzymology | 4 | 11.0 |
*Cell Cycle Proteins | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Mutation/immunology | 2 | 15.0 |
Conserved Sequence | 3 | 0.0 |
Protein-Tyrosine Kinase/*genetics/*metabolism | 2 | 9.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Dosage Compensation (Genetics) | 3 | 2.0 |
Sequence Deletion | 4 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Agammaglobulinemia/*genetics/*immunology | 2 | 66.0 |
Alternative Splicing | 2 | 0.0 |
Transcription Factor, Sp1/*metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/deficiency/*genetics | 2 | 33.0 |
Mutagenesis, Insertional | 2 | 0.0 |
Membrane Microdomains/metabolism | 2 | 6.0 |
DNA/genetics | 2 | 0.0 |
*Sequence Deletion | 4 | 1.0 |
DNA Primers/chemistry | 4 | 0.0 |
Amino Acids/genetics | 2 | 6.0 |
Blotting, Southern | 3 | 0.0 |
In Vitro | 3 | 0.0 |
Agammaglobulinemia/*immunology | 2 | 16.0 |
Gene Library | 2 | 0.0 |
Karyotyping | 2 | 0.0 |
Bone Marrow/enzymology | 2 | 9.0 |
T-Lymphocytes/*enzymology | 2 | 3.0 |
Sensitivity and Specificity | 2 | 0.0 |
Chromosomes, Human, X/genetics | 2 | 10.0 |
Amides/*pharmacology | 2 | 20.0 |
Nitriles/*pharmacology | 2 | 8.0 |
Amino Acid Motifs | 2 | 0.0 |
Antigens, CD40/*metabolism | 2 | 4.0 |
B-Lymphocytes/*enzymology/*immunology | 2 | 50.0 |